- Home
- FCEL vs ALEC Comparison
FCEL vs ALEC Comparison
Compare FCEL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCEL
- ALEC
- Stock Information
- Founded
- FCEL 1969
- ALEC 2013
- Country
- FCEL United States
- ALEC United States
- Employees
- FCEL N/A
- ALEC N/A
- Industry
- FCEL Industrial Machinery/Components
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FCEL Energy
- ALEC Health Care
- Exchange
- FCEL Nasdaq
- ALEC Nasdaq
- Market Cap
- FCEL 198.3M
- ALEC 232.6M
- IPO Year
- FCEL 1992
- ALEC 2019
- Fundamental
- Price
- FCEL $10.32
- ALEC $1.95
- Analyst Decision
- FCEL Hold
- ALEC Buy
- Analyst Count
- FCEL 4
- ALEC 6
- Target Price
- FCEL $29.06
- ALEC $11.75
- AVG Volume (30 Days)
- FCEL 1.7M
- ALEC 2.0M
- Earning Date
- FCEL 12-19-2024
- ALEC 11-06-2024
- Dividend Yield
- FCEL N/A
- ALEC N/A
- EPS Growth
- FCEL N/A
- ALEC N/A
- EPS
- FCEL N/A
- ALEC N/A
- Revenue
- FCEL $85,268,000.00
- ALEC $61,508,000.00
- Revenue This Year
- FCEL N/A
- ALEC N/A
- Revenue Next Year
- FCEL $88.40
- ALEC $71.71
- P/E Ratio
- FCEL N/A
- ALEC N/A
- Revenue Growth
- FCEL N/A
- ALEC N/A
- 52 Week Low
- FCEL $5.45
- ALEC $1.85
- 52 Week High
- FCEL $55.20
- ALEC $8.90
- Technical
- Relative Strength Index (RSI)
- FCEL 51.49
- ALEC 26.45
- Support Level
- FCEL $10.30
- ALEC $1.85
- Resistance Level
- FCEL $13.70
- ALEC $2.50
- Average True Range (ATR)
- FCEL 1.28
- ALEC 0.17
- MACD
- FCEL -0.02
- ALEC 0.02
- Stochastic Oscillator
- FCEL 17.43
- ALEC 13.69
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.